Director/PDMR Shareholding

28 Jun 2006 17:39

Cyprotex PLC28 June 2006 Press release 28 June 2006 Cyprotex PLC Director's Dealings Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that Mr Russell Gibbs, Chief Financial Officer ofthe Company, bought on Tuesday 27 June 2006 50,000 ordinary shares of 0.1p eachin the capital of the Company at a price of 6.50p per share. As a consequence of this purchase, the total number of shares of Cyprotex heldby Mr Gibbs represents less than 0.1% of the issued share capital. - Ends - For further information: Cyprotex PLC Robert Morrisson Atwater Tel: 016 2550 5100 ir@cyprotex.com www.cyprotex.com Code Securities Limited Richard Potts Tel: 020 7776 1200 RVP@nomuracode.com www.codesecurities.com Media enquiries: Abchurch Heather Salmond / Georgina Bonham Tel: 020 7398 7700 heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange